Report Detail
Global Human Varicella-Zoster Immunoglobulin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4744894 |
- 28 September, 2026 |
- Global |
- 91 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Human Varicella-Zoster Immunoglobulin market size was valued at US$ 180 million in 2025 and is forecast to a readjusted size of US$ 225 million by 2032 with a CAGR of 3.3% during review period.
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.
This report is a detailed and comprehensive analysis for global Human Varicella-Zoster Immunoglobulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Varicella-Zoster Immunoglobulin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Varicella-Zoster Immunoglobulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Varicella-Zoster Immunoglobulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Human Varicella-Zoster Immunoglobulin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Varicella-Zoster Immunoglobulin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Varicella-Zoster Immunoglobulin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio Products Laboratory, MassBiologics, Saol Therapeutics, Aptevo Biotherapeutics Llc, Ki Biopharma Llc, Cangene Biopharma, Kamada, Salmedon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Varicella-Zoster Immunoglobulin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Freeze-dried Powder
Injection
Market segment by Application
Hospital
Clinic
Major players covered
Bio Products Laboratory
MassBiologics
Saol Therapeutics
Aptevo Biotherapeutics Llc
Ki Biopharma Llc
Cangene Biopharma
Kamada
Salmedon
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Varicella-Zoster Immunoglobulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Varicella-Zoster Immunoglobulin, with price, sales quantity, revenue, and global market share of Human Varicella-Zoster Immunoglobulin from 2021 to 2026.
Chapter 3, the Human Varicella-Zoster Immunoglobulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Varicella-Zoster Immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Varicella-Zoster Immunoglobulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Varicella-Zoster Immunoglobulin.
Chapter 14 and 15, to describe Human Varicella-Zoster Immunoglobulin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Freeze-dried Powder
- 1.3.3 Injection
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Human Varicella-Zoster Immunoglobulin Market Size & Forecast
- 1.5.1 Global Human Varicella-Zoster Immunoglobulin Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Human Varicella-Zoster Immunoglobulin Sales Quantity (2021-2032)
- 1.5.3 Global Human Varicella-Zoster Immunoglobulin Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Bio Products Laboratory
- 2.1.1 Bio Products Laboratory Details
- 2.1.2 Bio Products Laboratory Major Business
- 2.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
- 2.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Bio Products Laboratory Recent Developments/Updates
- 2.2 MassBiologics
- 2.2.1 MassBiologics Details
- 2.2.2 MassBiologics Major Business
- 2.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
- 2.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 MassBiologics Recent Developments/Updates
- 2.3 Saol Therapeutics
- 2.3.1 Saol Therapeutics Details
- 2.3.2 Saol Therapeutics Major Business
- 2.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
- 2.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Saol Therapeutics Recent Developments/Updates
- 2.4 Aptevo Biotherapeutics Llc
- 2.4.1 Aptevo Biotherapeutics Llc Details
- 2.4.2 Aptevo Biotherapeutics Llc Major Business
- 2.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
- 2.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Aptevo Biotherapeutics Llc Recent Developments/Updates
- 2.5 Ki Biopharma Llc
- 2.5.1 Ki Biopharma Llc Details
- 2.5.2 Ki Biopharma Llc Major Business
- 2.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
- 2.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ki Biopharma Llc Recent Developments/Updates
- 2.6 Cangene Biopharma
- 2.6.1 Cangene Biopharma Details
- 2.6.2 Cangene Biopharma Major Business
- 2.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
- 2.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Cangene Biopharma Recent Developments/Updates
- 2.7 Kamada
- 2.7.1 Kamada Details
- 2.7.2 Kamada Major Business
- 2.7.3 Kamada Human Varicella-Zoster Immunoglobulin Product and Services
- 2.7.4 Kamada Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Kamada Recent Developments/Updates
- 2.8 Salmedon
- 2.8.1 Salmedon Details
- 2.8.2 Salmedon Major Business
- 2.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
- 2.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Salmedon Recent Developments/Updates
3 Competitive Environment: Human Varicella-Zoster Immunoglobulin by Manufacturer
- 3.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Human Varicella-Zoster Immunoglobulin Revenue by Manufacturer (2021-2026)
- 3.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2025
- 3.4.3 Top 6 Human Varicella-Zoster Immunoglobulin Manufacturer Market Share in 2025
- 3.5 Human Varicella-Zoster Immunoglobulin Market: Overall Company Footprint Analysis
- 3.5.1 Human Varicella-Zoster Immunoglobulin Market: Region Footprint
- 3.5.2 Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
- 3.5.3 Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Human Varicella-Zoster Immunoglobulin Market Size by Region
- 4.1.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2021-2032)
- 4.1.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2021-2032)
- 4.1.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2021-2032)
- 4.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value (2021-2032)
- 4.3 Europe Human Varicella-Zoster Immunoglobulin Consumption Value (2021-2032)
- 4.4 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value (2021-2032)
- 4.5 South America Human Varicella-Zoster Immunoglobulin Consumption Value (2021-2032)
- 4.6 Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 5.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Type (2021-2032)
- 5.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 6.2 Global Human Varicella-Zoster Immunoglobulin Consumption Value by Application (2021-2032)
- 6.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2021-2032)
7 North America
- 7.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 7.2 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 7.3 North America Human Varicella-Zoster Immunoglobulin Market Size by Country
- 7.3.1 North America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2021-2032)
- 7.3.2 North America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 8.2 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 8.3 Europe Human Varicella-Zoster Immunoglobulin Market Size by Country
- 8.3.1 Europe Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Region
- 9.3.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 10.2 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 10.3 South America Human Varicella-Zoster Immunoglobulin Market Size by Country
- 10.3.1 South America Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2021-2032)
- 10.3.2 South America Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Human Varicella-Zoster Immunoglobulin Market Size by Country
- 11.3.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Human Varicella-Zoster Immunoglobulin Market Drivers
- 12.2 Human Varicella-Zoster Immunoglobulin Market Restraints
- 12.3 Human Varicella-Zoster Immunoglobulin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Human Varicella-Zoster Immunoglobulin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Human Varicella-Zoster Immunoglobulin
- 13.3 Human Varicella-Zoster Immunoglobulin Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Human Varicella-Zoster Immunoglobulin Typical Distributors
- 14.3 Human Varicella-Zoster Immunoglobulin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Human Varicella-Zoster Immunoglobulin. Industry analysis & Market Report on Human Varicella-Zoster Immunoglobulin is a syndicated market report, published as Global Human Varicella-Zoster Immunoglobulin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Human Varicella-Zoster Immunoglobulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
